Skip to main content
logo
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.530
+0.010 (0.28%)
At close: Mar 19, 2026, 4:00 PM EDT
3.540
+0.010 (0.28%)
Pre-market: Mar 20, 2026, 5:53 AM EDT

AbCellera Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,0701,0248651,6572,8984,027
Market Cap Growth
50.26%18.29%-47.77%-42.83%-28.02%-62.83%
Enterprise Value
6806702949522,1063,305
Last Close Price
3.533.422.935.7110.1314.30
PE Ratio
----18.2826.24
Forward PE
-----51.81
PS Ratio
14.2413.6330.0243.575.9710.73
PB Ratio
1.101.060.821.442.353.93
P/TBV Ratio
1.221.160.901.682.754.85
P/FCF Ratio
----14.0221.63
P/OCF Ratio
----10.4516.46
EV/Sales Ratio
9.058.9210.1925.034.348.81
EV/EBITDA Ratio
----8.6215.10
EV/EBIT Ratio
----9.3616.17
EV/FCF Ratio
----10.1917.76
Debt / Equity Ratio
0.150.150.060.070.070.04
Debt / EBITDA Ratio
----0.320.18
Debt / FCF Ratio
----0.400.22
Net Debt / Equity Ratio
-0.40-0.40-0.53-0.59-0.65-0.67
Net Debt / EBITDA Ratio
2.002.002.503.21-3.29-3.12
Net Debt / FCF Ratio
2.242.243.005.66-3.89-3.67
Asset Turnover
0.060.060.020.030.340.32
Inventory Turnover
----108.8169.86
Quick Ratio
10.0710.078.956.938.377.44
Current Ratio
11.3211.329.817.338.677.71
Return on Equity (ROE)
-14.47%-14.47%-14.75%-12.27%14.03%16.54%
Return on Assets (ROA)
-9.99%-9.99%-12.41%-9.79%9.83%10.99%
Return on Invested Capital (ROIC)
-36.58%-40.50%-58.61%-52.82%38.64%49.05%
Return on Capital Employed (ROCE)
-16.80%-16.80%-22.00%-17.30%15.80%17.10%
Earnings Yield
-13.68%-14.30%-18.82%-8.84%5.47%3.81%
FCF Yield
-16.27%-17.00%-21.60%-7.29%7.13%4.62%
Buyback Yield / Dilution
-1.49%-1.49%-1.79%8.15%1.09%-20.96%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q